Seoul criteria for PiB(-) subcortical vascular dementia based on clinical and MRI variables

Neurology

Volumn 82, Issue 17, 2014, Pages 1529-1535

  Kim, Geon Ha ^a   Lee, Jae Hong ^b   Seo, Sang Won ^c   Ye, Byoung Seok ^c   Cho, Hanna ^c   Kim, Hee Jin ^c   Noh, Young ^d   Yoon, Cindy W ^e   Chin, Ju Hee ^c   Oh, Seung Jun ^b   Kim, Jae Seung ^b   Choe, Yearn Seong ^c   Lee, Kyung Han ^c   Kim, Sung Tae ^c   Jeong, Jee Hyang ^a   Na, Duk L ^c  

^a Ewha Womans University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Gachon University   (South Korea)

^e Inha University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN ATROPHY; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DSM-IV; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEMPORAL LOBE; WHITE MATTER LESION;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; ATROPHY; BRAIN; DEMENTIA, VASCULAR; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; OUTCOME ASSESSMENT (HEALTH CARE); POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REPUBLIC OF KOREA; STROKE, LACUNAR; VISION DISORDERS;

EID: 84902161314     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000360     Document Type: Article

References (35)

1. Menon U, Kelley RE Subcortical ischemic cerebrovascular dementia. Int Rev Neurobiol 2009; 84:21-33.
2. Chui HC. Subcortical ischemic vascular dementia. Neurol Clin 2007; 25:717-740. (Pubitemid 47061503)
3. Roman GC, Erkinjuntti T, Wallin A., Pantoni L, Chui HC Subcortical ischaemic vascular dementia. Lancet Neurol 2002; 1:426-436. (Pubitemid 37159153)
4. Englund E, Brun A, Persson B. Correlations between histopathologic white matter changes and proton MR relaxation times in dementia. Alzheimer Dis Assoc Disord 1987; 1:156-170.
5. Gold G, Bouras C, Canuto A., et al Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry 2002; 159:82-87. (Pubitemid 41070731)
6. Gearing M, Mirra SS, Hedreen J.C., Sumi SM, Hansen LA, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part X: neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995; 45:461-466.
7. Klunk WE, Engler H, Nordberg A., et al Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55:306-319. (Pubitemid 38269583)
8. Klunk WE, Wang Y, Huang G.F., Debnath ML, Holt DP, Mathis CA Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 2001; 69:1471-1484. (Pubitemid 32786721)
9. Lee JH, Kim SH, Kim G.H., et al Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology 2011; 77:18-25.
10. Nelissen N, Van Laere K, Thurfjell L, et al Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J Nucl Med 2009; 50:1251-1259.
11. Wong DF, Rosenberg PB, Zhou Y, et al In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med 2010; 51:913-920.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.
13. Fazekas F, Kleinert R, Offenbacher H., et al Pathologic correlates of incidental MRI white matter signal hyperin-tensities. Neurology 1993; 43:1683-1689. (Pubitemid 23307935)
14. Seo SW, Im K, Lee J.M., et al Cortical thickness in singleversus multiple-domain amnestic mild cognitive impairment. Neuroimage 2007; 36:289-297. (Pubitemid 46710453)
15. Kang Y, Na DL Seoul Neuropsychological Screening Battery: Professional Manual. Seoul: Human Brain Research & Consulting Co.; 2003.
16. Seo SW, Hwa Lee B, Kim EJ, et al Clinical significance of microbleeds in subcortical vascular dementia. Stroke 2007; 38:1949-1951. (Pubitemid 46847274)
17. Greenberg SM, Vernooij MW, Cordonnier C, et al Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009; 8:165-174.
18. Scheltens P, Leys D, Barkhof F., et al Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 967-972.
19. Jeon S, Yoon U, Park J.S., et al Fully automated pipeline for quantification and localization of white matter hyper-intensity in brain magnetic resonance image. Int J Imaging Syst Technol 2011; 21:193-200.
20. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3:32-35.
21. Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 2005; 16:73-81. (Pubitemid 40239280)
22. Mossman D, Somoza E. ROC curves, test accuracy, and the description of diagnostic tests. J Neuropsychiatry Clin Neurosci 1991; 3:330-333.
23. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54:774-781. (Pubitemid 32722180)
24. Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment: a critical update. Front Aging Neurosci 2013; 5:17.
25. Gold G, Giannakopoulos P, Herrmann F.R., Bouras C., Kovari E. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain 2007; 130:2830-2836. (Pubitemid 350033968)
26. Roman GC, Tatemichi TK, Erkinjuntti T, et al Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43:250-260. (Pubitemid 23060253)
27. Chui HC, Victoroff JI, Margolin D, Jagust W., Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992; 42:473-480.
28. Erkinjuntti T, Inzitari D, Pantoni L., et al Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials: is a focus on subcortical vascular dementia a solution? Ann NY Acad Sci 2000; 903:262-272. (Pubitemid 30251566)
29. Erkinjuntti T, Inzitari D, Pantoni L., et al Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000; 59:23-30. (Pubitemid 30479402)
30. Kalaria RN, Erkinjuntti T. Small vessel disease and subcortical vascular dementia. J Clin Neurol 2006; 2:1-11.
31. Wiederkehr S, Simard M, Fortin C., van Reekum R. Validity of the clinical diagnostic criteria for vascular dementia: a critical review. J Neuropsychiatry Clin Neurosci 2008; 20:162-177.
32. Chetelat G, La Joie R, Villain N, et al Amyloid imaging in cognitively normal individuals, at-risk populations and preclini-cal Alzheimer's disease. Neuroimage Clin 2013; 2:356-365.
33. Rowe CC, Ellis KA, Rimajova M, et al Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 2010; 31:1275-1283.
34. Ye BS, Kim GH, Cho H, et al Poor prognostic factors in subcortical vascular dementia: a longitudinal cohort study of amyloid PET imaging for subcortical vascular dementia. Alzheimer's Association International Conference; Boston; 2013:P4-P063.
35. Gouw AA, Seewann A, van der Flier WM, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011; 82:126-135.